Back to News
Market Impact: 0.2
Implantica announces successful completion of first RefluxStop® procedures in the U.S.
Source: PR Newswire
Healthcare & BiotechProduct LaunchesTechnology & Innovation
Implantica announced that the first procedures using its RefluxStop® device have taken place, but the provided article excerpt cuts off before specifying where or giving further details. RefluxStop is described as a device for treating acid reflux.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Magnificent 7 loses $1 trillion. The most eye-popping stats from Thursday's tech stock plunge
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Wall Street’s best post-midterm rally in 44 years lasted just one day—then $3 trillion vanished as chip stocks plunged over AI fears
- AI stocks plunge after election, driving down US markets
- Shield AI To Hit $28.8 Billion Value With $5.3 Billion Radar Acquisition
- We're raising our price target on Cardinal Health after another stellar quarter of profits